Article ID Journal Published Year Pages File Type
8691723 World Neurosurgery 2018 19 Pages PDF
Abstract
It is important for neurosurgeons to be aware of this rare entity. The treatment protocol remains controversial and is primarily guided by expert opinion. It is important to aggressively treat the patient with antibiotics followed by adjuvant therapy for malignancy. The timing and administration of adjuvant therapy are unclear. We suggest a delay of chemotherapy until at least 4 weeks of therapy with sensitive antibiotics.
Related Topics
Life Sciences Neuroscience Neurology
Authors
, , , , , , ,